• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏菌素和利福平的协同抗生素组合粉末具有高气雾化效率和防潮性能。

Synergistic antibiotic combination powders of colistin and rifampicin provide high aerosolization efficiency and moisture protection.

作者信息

Zhou Qi Tony, Gengenbach Thomas, Denman John A, Yu Heidi H, Li Jian, Chan Hak Kim

机构信息

Advanced Drug Delivery Group, Faculty of Pharmacy, The University of Sydney, Sydney, NSW, Australia.

出版信息

AAPS J. 2014 Jan;16(1):37-47. doi: 10.1208/s12248-013-9537-8. Epub 2013 Oct 16.

DOI:10.1208/s12248-013-9537-8
PMID:24129586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3889531/
Abstract

For many respiratory infections caused by multidrug-resistant Gram-negative bacteria, colistin is the only effective antibiotic despite its nephrotoxicity. A novel inhaled combination formulation of colistin with a synergistic antimicrobial component of rifampicin was prepared via co-spray drying, aiming to deliver the drug directly to the respiratory tract and minimize drug resistance and adverse effects. Synergistic antibacterial activity against Acinetobacter baumannii was demonstrated for the combination formulation with high emitted doses (96%) and fine particle fraction total (FPFtotal; 92%). Storage of the spray-dried colistin alone formulation in the elevated relative humidity (RH) of 75% resulted in a substantial deterioration in the aerosolization performance because the amorphous colistin powders absorbed significant amount of water up to 30% by weight. In contrast, the FPFtotal values of the combination formulation stored at various RH were unchanged, which was similar to the aerosolization behavior of the spray-dried rifampicin-alone formulation. Advanced surface chemistry measurements by XPS and ToF-SIMS demonstrated a dominance of rifampicin on the combination particle surfaces, which contributed to the moisture protection at the elevated RH. This study shows a novel inhalable powder formulation of antibiotic combination with the combined beneficial properties of synergistic antibacterial activity, high aerosolization efficiency, and moisture protection.

摘要

对于许多由耐多药革兰氏阴性菌引起的呼吸道感染,尽管粘菌素具有肾毒性,但它仍是唯一有效的抗生素。通过共喷雾干燥制备了一种新型的吸入用粘菌素与利福平协同抗菌成分的组合制剂,旨在将药物直接递送至呼吸道,并最大限度地减少耐药性和不良反应。对于高发射剂量(96%)和细颗粒分数总量(FPFtotal;92%)的组合制剂,证明了其对鲍曼不动杆菌具有协同抗菌活性。单独的喷雾干燥粘菌素制剂在75%的较高相对湿度(RH)下储存会导致雾化性能大幅下降,因为无定形粘菌素粉末吸收了高达30%重量的大量水分。相比之下,在不同RH条件下储存的组合制剂的FPFtotal值没有变化,这与喷雾干燥的单独利福平制剂的雾化行为相似。通过XPS和ToF-SIMS进行的先进表面化学测量表明,利福平在组合颗粒表面占主导地位,这有助于在较高RH下提供防潮保护。这项研究展示了一种新型的可吸入抗生素组合粉末制剂,具有协同抗菌活性、高雾化效率和防潮保护等综合有益特性。

相似文献

1
Synergistic antibiotic combination powders of colistin and rifampicin provide high aerosolization efficiency and moisture protection.黏菌素和利福平的协同抗生素组合粉末具有高气雾化效率和防潮性能。
AAPS J. 2014 Jan;16(1):37-47. doi: 10.1208/s12248-013-9537-8. Epub 2013 Oct 16.
2
Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections.抗生素成分对治疗泛耐药革兰氏阴性肺部感染的三联组合吸入性粉末制剂的体外杀菌效果、物理化学性质、气溶胶化和溶解的影响。
Int J Pharm. 2019 Apr 20;561:102-113. doi: 10.1016/j.ijpharm.2019.02.018. Epub 2019 Feb 21.
3
Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.新型吸入性复方粉剂,含无定形多黏菌素和结晶型利福喷汀,对铜绿假单胞菌浮游细胞和生物膜具有增强的抗菌活性,用于呼吸道感染
Mol Pharm. 2015 Aug 3;12(8):2594-603. doi: 10.1021/mp500586p. Epub 2014 Dec 24.
4
Effects of Surface Composition on the Aerosolisation and Dissolution of Inhaled Antibiotic Combination Powders Consisting of Colistin and Rifampicin.表面成分对由黏菌素和利福平组成的吸入性抗生素复方粉末雾化及溶解的影响
AAPS J. 2016 Mar;18(2):372-84. doi: 10.1208/s12248-015-9848-z. Epub 2015 Nov 24.
5
Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation.具有高效气溶胶化特性的黏菌素粉剂用于呼吸道感染:制备与体外评价。
J Pharm Sci. 2013 Oct;102(10):3736-47. doi: 10.1002/jps.23685. Epub 2013 Jul 31.
6
Composite particle formulations of colistin and meropenem with improved in-vitro bacterial killing and aerosolization for inhalation.多黏菌素与美罗培南复合颗粒制剂,改善了体外杀菌效果,并可通过雾化吸入方式给药。
Int J Pharm. 2018 Sep 5;548(1):443-453. doi: 10.1016/j.ijpharm.2018.07.010. Epub 2018 Jul 3.
7
Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections.将吸湿的卡那霉素与疏水性药物利福平共喷雾干燥,以改善用于治疗呼吸道感染的卡那霉素粉末的空气悬浮性。
Int J Pharm. 2018 Apr 25;541(1-2):26-36. doi: 10.1016/j.ijpharm.2018.02.026. Epub 2018 Feb 17.
8
Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.协同黏菌素增强吸入型无定形环丙沙星粉末制剂的物理稳定性和雾化效果
Mol Pharm. 2018 Sep 4;15(9):4004-4020. doi: 10.1021/acs.molpharmaceut.8b00445. Epub 2018 Aug 3.
9
Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections.可吸入脂质体粉末制剂用于协同递送达托霉素和黏菌素治疗多重耐药革兰氏阴性肺部感染
Int J Pharm. 2020 Feb 15;575:118915. doi: 10.1016/j.ijpharm.2019.118915. Epub 2019 Dec 6.
10
L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.L-亮氨酸作为一种辅料对高吸湿性喷雾干燥粉末体外雾化性能的防潮作用。
Eur J Pharm Biopharm. 2016 May;102:132-41. doi: 10.1016/j.ejpb.2016.02.010. Epub 2016 Mar 9.

引用本文的文献

1
Particle surface coating for dry powder inhaler formulations.用于干粉吸入剂制剂的颗粒表面包衣
Expert Opin Drug Deliv. 2025 May;22(5):711-727. doi: 10.1080/17425247.2025.2482052. Epub 2025 Mar 26.
2
Impact of Co-Spray Drying with Leucine or Trileucine on Aerosol Performance, In Vitro Dissolution, and Cellular Uptake of Colistin Powder Formulations for Inhalation.亮氨酸或三亮氨酸共喷雾干燥对吸入用黏菌素粉末制剂的气溶胶性能、体外溶出度和细胞摄取的影响
Pharmaceutics. 2025 Feb 5;17(2):199. doi: 10.3390/pharmaceutics17020199.
3
Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects.抗生素肺部给药:现状与未来展望
Pharmaceutics. 2025 Jan 15;17(1):111. doi: 10.3390/pharmaceutics17010111.
4
Liposomal Formulation Reduces Transport and Cell Uptake of Colistin in Human Lung Epithelial Calu-3 Cell and 3D Human Lung Primary Tissue Models.脂质体制剂降低多粘菌素在人肺上皮细胞 Calu-3 细胞和 3D 人肺原代组织模型中的转运和细胞摄取。
AAPS PharmSciTech. 2024 Feb 17;25(3):40. doi: 10.1208/s12249-024-02753-6.
5
Engineering Inhalable Therapeutic Particles: Conventional and Emerging Approaches.工程化可吸入治疗颗粒:传统方法与新兴方法
Pharmaceutics. 2023 Nov 30;15(12):2706. doi: 10.3390/pharmaceutics15122706.
6
Development of Large Hollow Particles for Pulmonary Delivery of Cyclosporine A.用于环孢素A肺部递送的大型中空颗粒的研发。
Pharmaceutics. 2023 Aug 25;15(9):2204. doi: 10.3390/pharmaceutics15092204.
7
Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis.载 D-LAK 抗菌肽和卷曲霉素的联合递药吸入粉体制剂用于治疗耐药结核病。
Pharm Res. 2023 May;40(5):1073-1086. doi: 10.1007/s11095-023-03488-y. Epub 2023 Mar 3.
8
Liposomes or Extracellular Vesicles: A Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery.脂质体或细胞外囊泡:用于肺部药物递送的两种脂质双层囊泡的全面比较
Polymers (Basel). 2023 Jan 7;15(2):318. doi: 10.3390/polym15020318.
9
Engineering Alginate-Based Dry Powder Microparticles to a Size Suitable for the Direct Pulmonary Delivery of Antibiotics.将基于藻酸盐的干粉微粒加工至适合抗生素直接肺部给药的尺寸。
Pharmaceutics. 2022 Dec 9;14(12):2763. doi: 10.3390/pharmaceutics14122763.
10
Stability of Inhaled Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticle Dry Powder Inhaler Formulation in High Stressed Conditions.高应力条件下吸入用载环丙沙星聚(2-乙基-2-恶唑啉)纳米颗粒干粉吸入剂配方的稳定性
Pharmaceuticals (Basel). 2022 Oct 2;15(10):1223. doi: 10.3390/ph15101223.

本文引用的文献

1
Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation.具有高效气溶胶化特性的黏菌素粉剂用于呼吸道感染:制备与体外评价。
J Pharm Sci. 2013 Oct;102(10):3736-47. doi: 10.1002/jps.23685. Epub 2013 Jul 31.
2
Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/pharmacodynamic model.利福平与多粘菌素联合应用对体外药代动力学/药效学模型中多重耐药鲍曼不动杆菌的协同作用。
Antimicrob Agents Chemother. 2013 Aug;57(8):3738-45. doi: 10.1128/AAC.00703-13. Epub 2013 May 28.
3
Effect of device design on the aerosolization of a carrier-based dry powder inhaler--a case study on Aerolizer(®) Foradile (®).载药型干粉吸入器装置设计对药物气溶胶化的影响——以 Aerolizer(®) Foradile (®)为例。
AAPS J. 2013 Apr;15(2):511-22. doi: 10.1208/s12248-013-9458-6. Epub 2013 Feb 1.
4
Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study.注射用黏菌素硫酸钙(Colobreathe DPI)在囊性纤维化患者中的安全性、疗效和便利性:一项随机研究。
Thorax. 2013 Apr;68(4):344-50. doi: 10.1136/thoraxjnl-2012-202059. Epub 2012 Nov 7.
5
A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics.一种包含三种一线抗结核抗生素的新型可吸入干粉制剂。
Eur J Pharm Biopharm. 2013 Feb;83(2):285-92. doi: 10.1016/j.ejpb.2012.08.007. Epub 2012 Sep 13.
6
Characterisation of high dose aerosols from dry powder inhalers.干粉吸入器高剂量气溶胶的特性。
Int J Pharm. 2012 Nov 1;437(1-2):242-9. doi: 10.1016/j.ijpharm.2012.08.020. Epub 2012 Aug 19.
7
Computational fluid dynamics (CFD) assisted performance evaluation of the Twincer™ disposable high-dose dry powder inhaler.计算流体动力学(CFD)辅助评估 Twincer™ 一次性高剂量干粉吸入器的性能。
J Pharm Pharmacol. 2012 Sep;64(9):1316-25. doi: 10.1111/j.2042-7158.2012.01511.x. Epub 2012 Apr 23.
8
Inhaled colistin for lower respiratory tract infections.吸入性黏菌素治疗下呼吸道感染。
Expert Opin Drug Deliv. 2012 Mar;9(3):333-42. doi: 10.1517/17425247.2012.660480. Epub 2012 Feb 14.
9
Drug-lactose binding aspects in adhesive mixtures: controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces.药物-乳糖结合方面的研究:通过改变乳糖载体表面来控制干粉吸入剂配方中的性能。
Adv Drug Deliv Rev. 2012 Mar 15;64(3):275-84. doi: 10.1016/j.addr.2011.07.002. Epub 2011 Jul 18.
10
Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.多中心研究中重症患者的黏菌素甲磺酸盐和形成的黏菌素群体药代动力学为各类患者提供了给药建议。
Antimicrob Agents Chemother. 2011 Jul;55(7):3284-94. doi: 10.1128/AAC.01733-10. Epub 2011 May 9.